Eli Lilly and Boehringer Ingelheim Sponsored Symposium

Monday, 2 March 2009 12:30 - 14:15, Plaza Room 1 & 2

Chair Professor Michael Berk Department of Clinical and Biomedical Sciences: Barwon Health, The University of Melbourne, VictoriaAustralia
Neurobiology of Depression
  • A/Prof Charles Raison, Emory University School of Medicine, United States
From reality of secondary prevention to the hope of primary prevention
  • Prof Michael Berk, University of Melbourne, Australia
The depressive journey: a model of addressing the risk and disability over time
  • Gordon B Parker, Black Dog Institute, Australia